SAGE Publishing and The Foundation for Gender-Specific Medicine publish Gender and the Genome
SAGE Publishing today announces a partnership with The Foundation for Gender-Specific Medicine to publish Gender and the Genome. A peer-reviewed, open access publication, the journal examines ways in which biological sex influences new science of the 21st century, particularly in the areas of technology and human life.
Comprised of original research, reviews, and commentaries, Gender and the Genome covers topics such as:
- Sex-specific differences in genomic, cellular, tissue, and whole animal function
- New life forms generated by synthetic biology
- Technological advances meant to enhance the function in humans
- Manufacture and usefulness of robotic devices
- Commentaries by ethicists, theologians, anthropologists, epidemiologists, and sociologists/social scientists on the achievements of 21st century science
The journal integrates the pivotal scientific developments of gender-specific medicine and the interpretation of the human genome. With an editorial board of renowned scholars from around the globe, Gender and the Genome engages the community of molecular biologists, engineers, ethicists, anthropologists, and legal experts in a dialogue about the nature and implications of 21st century technology.
The journal is also the official publication of the International Society for Gender Medicine and The Israeli Society for Gender-and Sex Conscious Medicine. It is supported in part by a grant from Isobel and Marvin Slomowitz. For more information, please visit the website for Gender and the Genome.
# # #
Sara Miller McCune founded SAGE Publishing in 1965 to support the dissemination of usable knowledge and educate a global community. SAGE is a leading international provider of innovative, high-quality content publishing more than 1,000 journals and over 800 new books each year, spanning a wide range of subject areas. Our growing selection of library products includes archives, data, case studies and video. SAGE remains majority owned by our founder and after her lifetime will become owned by a charitable trust that secures the company’s continued independence. Principal offices are located in Los Angeles, London, New Delhi, Singapore, Washington, D.C. and Melbourne. www.sagepublishing.com
Founded in 2006 as a continuation of the Partnership for Gender-Specific Medicine at Columbia University, The Foundation for Gender-Specific Medicine, Inc. (FGSM) was established in response to the new interest in the direct investigation of women’s health that began in the early 1990’s and which revealed that the differences between men and women were not only completely unexpected but more than had been even imagined and involved every organ in the body. As the first studies began to be published, it became apparent that men could not be considered normative for the entire human race, but that direct testing of both sexes was necessary for an accurate view of not only normal physiology but of the sex-specific experience of the disease. A new science of gender-specific medicine emerged and continues to expand. Gender-specific medicine is not the study of women’s health; it is the study of ways in which biological sex and gender impact normal human function and the differences in men’s and women’s experience of disease. Go to gendermed.org/ for more information.